Clinical Trial Update: Evaluation of Progression of Myopia in Children Treated With Vitamin B2 and Outdoor Sunlight Exposure [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating progression of myopia in children treated with riboflavin (Vitamin B2) and outdoor sunlight exposure has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia
• Refractive Errors

Drugs mentioned

• Vitamin B2 (riboflavin) (riboflavin)

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Axial Myopia, Refractive Errors | Phase 2 | Status: SUSPENDED